Business Description
Perk Labs Inc
NAICS : 511210
SIC : 7721
ISIN : CA3767901018
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.06 | |||||
Equity-to-Asset | 0.66 | |||||
Debt-to-Equity | 0.09 | |||||
Debt-to-EBITDA | -0.22 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | -8.64 | |||||
Beneish M-Score | 102.41 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 32.8 | |||||
3-Year EPS without NRI Growth Rate | 33.7 | |||||
3-Year FCF Growth Rate | 32 | |||||
3-Year Book Growth Rate | -68.5 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 53.5 | |||||
9-Day RSI | 54.46 | |||||
14-Day RSI | 54.07 | |||||
6-1 Month Momentum % | -25 | |||||
12-1 Month Momentum % | -68.97 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.04 | |||||
Quick Ratio | 0.04 | |||||
Cash Ratio | 0.01 | |||||
Days Inventory | 17.32 | |||||
Days Sales Outstanding | 162.22 | |||||
Days Payable | 5369.83 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -14 | |||||
Shareholder Yield % | -8.07 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 6.35 | |||||
Operating Margin % | -3106.35 | |||||
Net Margin % | -3166.67 | |||||
FCF Margin % | -1240.91 | |||||
ROE % | -96.08 | |||||
ROA % | -63.9 | |||||
ROIC % | -67.82 | |||||
ROC (Joel Greenblatt) % | -7327.07 | |||||
ROCE % | -90.52 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 1.36 | |||||
EV-to-EBIT | -3.43 | |||||
EV-to-EBITDA | -3.55 | |||||
EV-to-Revenue | 106.2 | |||||
EV-to-FCF | -8.54 | |||||
Earnings Yield (Greenblatt) % | -29.08 | |||||
FCF Yield % | -12.41 |